| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.96B | 11.59B | 11.99B | 11.91B | 11.28B | 10.68B |
| Gross Profit | 8.50B | 8.10B | 8.38B | 8.34B | 7.96B | 7.43B |
| EBITDA | 379.76M | 280.17M | 507.92M | 325.33M | 403.04M | 294.11M |
| Net Income | 555.94M | 79.62M | 122.01M | 511.95M | 103.92M | -67.62M |
Balance Sheet | ||||||
| Total Assets | 8.96B | 8.36B | 8.72B | 8.89B | 8.98B | 9.20B |
| Cash, Cash Equivalents and Short-Term Investments | 2.82B | 3.03B | 3.15B | 3.30B | 3.02B | 3.08B |
| Total Debt | 37.56M | 73.01M | 80.16M | 386.85M | 811.74M | 1.41B |
| Total Liabilities | 3.26B | 2.71B | 2.99B | 3.14B | 3.66B | 3.85B |
| Stockholders Equity | 5.70B | 5.65B | 5.73B | 5.74B | 5.33B | 5.34B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 31.51M | 471.66M | 291.36M | 305.95M | 676.81M |
| Operating Cash Flow | 0.00 | 63.39M | 490.06M | 322.86M | 310.16M | 690.67M |
| Investing Cash Flow | 0.00 | 2.14M | -194.39M | 583.64M | 392.20M | 3.12M |
| Financing Cash Flow | 0.00 | -182.44M | -449.58M | -628.98M | -760.27M | 828.83M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥1.10T | 9.13 | 9.37% | 2.59% | -1.22% | -10.82% | |
71 Outperform | ¥582.92B | 14.44 | 9.06% | 1.84% | 0.42% | 20.25% | |
66 Neutral | ¥665.53B | 22.09 | 7.58% | 2.58% | 6.52% | -31.67% | |
66 Neutral | ¥311.67B | 2.68 | 4.97% | 2.01% | 2.00% | -68.35% | |
64 Neutral | ¥1.93T | 18.88 | 17.34% | 0.72% | 18.58% | 7.54% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥6.44B | 32.00 | ― | 1.82% | -2.58% | -8.24% |